SGLT2 inhibitor empagliflozin prevents anthracycline-induced cardiotoxicity in a large-animal model
Event: ESC Congress 2024
Topic: Heart Failure
Session: Novel targets against myocardial damage
Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity
Event: Heart Failure 2023
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: ePosters in chronic heart failure - pathophysiology and mechanisms 1
